Chronic peritoneal dialysis (PD) continues to be an option in the treatment of end-stage renal disease (ESRD). Medical, social, and logistic considerations are needed to determine the most suitable dialysis option for an ESRD patient. Peritoneal dialysis has been advancing in terms of technique, new exchange systems, and a new generation of solutions. A survival advantage for PD patients has been noted over the first 1 – 2 years after the onset of the dialysis. Most patients may need both dialytic modalities in time, and therefore the sequence of the treatment options is important. Compared with hemodialysis patients, PD patients seem much more satisfied in most of the studies that evaluate quality of life during treatment. A preference for PD may be more advantageous in the pre-transplantation period. Moreover, much lower doses of erythropoietin have been shown to be sufficient for PD patients. Also, PD has been reported to protect residual renal functions better in many studies.
GrassmannA., GiobergeS., MoellerS., BrownG.End-stage renal disease: global demographics in 2005 and observed trends.Artif Organs2006; 30: 895–7.
2.
BloembergenW.E., PortF.K., MaugerE.A., WolfeR.A.A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis.J Am Soc Nephrol1995; 6: 177–83.
3.
FentonS.S., SchaubelD.E., DesmeulesM., MorrisonH.I., MaoY., CoplestonP.Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates.Am J Kidney Dis1997; 30: 334–42.
4.
HeafJ.G., LøkkegaardH., MadsenM.Initial survival advantage of peritoneal dialysis relative to haemodialysis.Nephrol Dial Transplant2002; 17: 112–17.
5.
TermorshuizenF., KorevaarJ.C., DekkerF.W., Van ManenJ.G., BoeschotenE.W., KredietR.T., on behalf of the Netherlands Cooperative Study on the Adequacy Dialysis Study Group. Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2.J Am Soc Nephrol2003; 14: 2851–60.
6.
CollinsA.J., HaoW., XiaH., EbbenJ.P., EversonS.E., ConstantiniE.G.Mortality risks of peritoneal dialysis and hemodialysis.Am J Kidney Dis1999; 34: 1065–74.
7.
AstorB.C., EustaceJ.A., PoweN.R., KlagM.J., FinkN.E., CoreshJ.on behalf of the CHOICE Study. Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes In Caring for ESRD (CHOICE) Study.J Am Soc Nephrol2005; 16: 1449–55.
8.
SipahiogluM.H., AybalA., UnalA., TokgozB., OymakO., UtasC.Patient and technique survival and factors affecting mortality on peritoneal dialysis in Turkey: 12 years’ experience in a single center.Perit Dial Int2008; 28: 238–45.
9.
BarendseS.M., SpeightJ., BradleyC.The Renal Treatment Satisfaction Questionnaire (RTSQ): a measure of satisfaction with treatment for chronic kidney failure.Am J Kidney Dis2005; 45: 572–9.
10.
RubinH.R., FinkN.E., PlantingaL.C., SadlerJ.H., KligerA.S., PoweN.R.Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis.JAMA2004; 291: 697–703.
11.
JuergensenE., WuerthD., FinkelsteinS.H., JuergensenP.H., BekuiA., FinkelsteinF.O.Hemodialysis and peritoneal dialysis: patients’ assessment of their satisfaction with therapy and the impact of the therapy on their lives.Clin J Am Soc Nephrol2006; 1: 1191–6.
12.
Van BiesenW., VeysN., VanholderR., LameireN.The impact of the pre-transplant renal replacement modality on outcome after cadaveric kidney transplantation: the Ghent experience.Contrib Nephrol2006; 150: 254–8.
13.
Goldfarb–RumyantzevA.S., HurdleJ.F., ScandlingJ.D., BairdB.C., CheungA.K.The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival.Am J Kidney Dis2005; 46: 537–49.
14.
Pérez FontánM., Rodríguez–CarmonaA., BouzaP., García FalcónT., AdevaM., ValdésF.Delayed graft function after renal transplantation in patients undergoing peritoneal dialysis and hemodialysis.Adv Perit Dial1996; 12: 101–4.
15.
LevinA., ThompsonC.R., EthierJ., CarlisleE.J., TobeS., MendelssohnD.Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin.Am J Kidney Dis1999; 34: 125–34.
16.
SnyderJ.J., FoleyR.N., GilbertsonD.T., VoneshE.F., CollinsA.J.Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States.J Am Soc Nephrol2004; 15: 174–9.
17.
ChurchillD.N., TaylorD.W., KeshaviahP.R. and the CANUSA Peritoneal Dialysis Study Group Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes.J Am Soc Nephrol1996; 7: 198–207.
18.
MisraM., VoneshE., Van StoneJ.C., MooreH.L., ProwantB., NolphK.D.Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis.Kidney Int2001; 59: 754–63.
19.
LangS.M., BergnerA., TöpferM., SchifflH.Preservation of residual renal function in dialysis patients: effects of dialysis-technique–related factors.Perit Dial Int2001; 21: 52–7.
